CDTX vs WELL · rev $1.3M vs P/E 100, rev $10.84B
Cidara Therapeutics Inc (CDTX) versus Welltower Inc (WELL) — a side-by-side from cached financials, not a winner call.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
Welltower Inc (WELL) is a reit - healthcare facilities company listed on NYSE.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
Latest reported WELL revenue for 2025-12-31 was $10.84B. Net income was $936.8M. Revenue was up 35.6% from 2024-12-31 to 2025-12-31. WELL currently screens at market cap $145.81B and trailing P/E 99.8.
CDTX currently screens at market cap $6.96B. WELL currently screens at market cap $145.81B and trailing P/E 99.8.
Not investment advice. Open the CDTX and WELL stock pages for the full models.
Not investment advice.